Skip to content

ARTHUR PHARMA

Active
Private limited companyfounded 20251 yr activeKleinenbergstraat 73, 1932 Zaventem, BelgiumKBO/BCE: BE 1020.149.493
Summary

ARTHUR PHARMA has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €61,718 and a net result of €58,718. Its solvency ranks better than 77% of 18716 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.1% (low).

Checked score

Score 2025
Axes
Profitability100
Solvency91
Growth-
Track record67
Bankruptcy probability, 12 months
1.1% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €4,500 at 30 days acceptable
Liquidity ample (current ratio 2.92; short-term debt: 34.2% and cash: 24.4% of total assets), and 34.2% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
65.8%
Return on assets
62.6%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-07-2026, 2 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
2 d early
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

ARTHUR PHARMA was incorporated on 19 February 2025 as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€61,718
Total assets
€93,827
Net result
€58,718
Working capital
€61,718

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Equity and liabilities €93,827
Equity €61,718
Debt €32,109
Debt finances 34.2% of the balance-sheet total.
Key figures and ratios
2025 value
Current ratio
2.92
Debt to equity
0.52
ROE
95.1%
ROA
62.6%
Debt ≤ 1 year
€32,109
Income taxes
€22,585

Peer companies

Historical observation

Of the 11,280 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 97% are still going.

  • Micro
  • under 2 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.7% went bankrupt
2.6% stopped otherwise
97% still going

For this company itself Checked computes a higher bankruptcy probability: 1.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 11,280 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 32 lines
Balance sheet Code2025
Assets
Total assets20/58€93,827
Current assets29/58€93,827
Amounts receivable within one year40/41€70,900
Trade receivables40€13,425
Other amounts receivable41€57,475
Cash at bank and in hand54/58€22,927
Equity and liabilities
Total equity and liabilities10/49€93,827
Equity10/15€61,718
Contributions10/11€3,000
Reserves13€58,718
Distributable reserves133€58,718
Amounts payable17/49€32,109
Amounts payable within one year42/48€32,109
Trade debts44€1,070
Suppliers440/4€1,070
Taxes, remuneration and social security45€31,039
Taxes450/3€28,339
Remuneration and social security454/9€2,700
Income statement Code2025
Other operating charges640/8€63
Gross operating margin9900€78,727
Operating profit (loss)9901€78,664
Financial income75/76B€2,677
Recurring financial income75€2,677
Financial charges65/66B€38
Recurring financial charges65€38
Profit (loss) for the period before taxes9903€81,303
Income taxes67/77€22,585
Profit (loss) for the period9904€58,718
Profit (loss) for the period to be appropriated9905€58,718
Appropriation of the result
Profit (loss) to be appropriated9906€58,718
Transfer to equity691/2€58,718
To other reserves6921€58,718

The notes to these accounts (2 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Other operating charges640/8€63
Gross operating margin9900€78,727
Operating profit (loss)9901€78,664
Financial income75/76B€2,677
Recurring financial income75€2,677
Financial charges65/66B€38
Recurring financial charges65€38
Profit (loss) for the period before taxes9903€81,303
Income taxes67/77€22,585
Profit (loss) for the period9904€58,718
Profit (loss) for the period to be appropriated9905€58,718
Line2025
Assets
Total assets20/58€93,827
Current assets29/58€93,827
Amounts receivable within one year40/41€70,900
Trade receivables40€13,425
Other amounts receivable41€57,475
Cash at bank and in hand54/58€22,927
Equity and liabilities
Total equity and liabilities10/49€93,827
Equity10/15€61,718
Contributions10/11€3,000
Reserves13€58,718
Distributable reserves133€58,718
Amounts payable17/49€32,109
Amounts payable within one year42/48€32,109
Trade debts44€1,070
Suppliers440/4€1,070
Taxes, remuneration and social security45€31,039
Taxes450/3€28,339
Remuneration and social security454/9€2,700
Line2025
Profit (loss) for the period9904€58,718
Operating cash flow (approximation)€58,718

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
29-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
NBB filing
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zaventem · 1 establishment unit since 2025
seat establishment The establishment unit on the map
Ground area
378 m²
Building footprint
113 m²
Volume, LiDAR
813 m³
Parcel 23078C0158/00X002, Flanders · tallest building 11.2 m, ±3 floors. Linked by address, not a title deed.
2 companies at this address See who is registered here
1 establishment unit
ARTHUR PHARMA
Kleinenbergstraat 73, 1932 ZaventemRetail sale of pharmaceutical products
since 20252.370.604.081
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
23078C0158/00X002 Flanders 378 m² 1 · 113 m² 11.2 m · 3 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 5,220 companies in sector 47730 we hold annual accounts for 3,862. 3,000 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded19-02-2025
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID 0208:1020149493
Also 9925:BE1020149493
Registered 09-12-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 30 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.